抑制性自然杀伤细胞受体NKR-P1对Ocil/Clr-b的自身识别缺失。

Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors.

作者信息

Carlyle James R, Jamieson Amanda M, Gasser Stephan, Clingan Christopher S, Arase Hisashi, Raulet David H

机构信息

Department of Molecular and Cell Biology and Cancer Research Laboratory, University of California, 485 Life Sciences Addition, Berkeley, CA 94720, USA.

出版信息

Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3527-32. doi: 10.1073/pnas.0308304101. Epub 2004 Feb 27.

Abstract

The NKR-P1 family of C-type lectin-like receptors are expressed on natural killer (NK) cells and NKT cells. We report the cloning and characterization of a cognate ligand for the inhibitory mouse NK receptors (NKR)-P1B and NKR-P1D (CD161b/d). The NKR-P1B/D ligand is osteoclast inhibitory lectin (Ocil), also known as Clr-b, a member of a previously cloned group of C-type lectin-related (Clr) proteins linked to the NKR-P1 receptors in the mouse NK gene complex (NKC). Expression of Ocil/Clr-b on mouse tumor cell lines inhibits NK cell-mediated killing. Inhibition is blocked with a new mAb (4A6) specific for Ocil/Clr-b. By using 4A6 mAb, we demonstrate that Ocil/Clr-b is displayed at high levels on nearly all hematopoietic cells, with the exception of erythrocytes, in a pattern that is similar to that of class I MHC molecules. Remarkably, Ocil/Clr-b is frequently down-regulated on mouse tumor cell lines, indicating a role for this receptor-ligand system in a new form of "missing self-recognition" of tumor cells.

摘要

C型凝集素样受体的NKR-P1家族在自然杀伤(NK)细胞和NKT细胞上表达。我们报告了小鼠抑制性NK受体(NKR)-P1B和NKR-P1D(CD161b/d)同源配体的克隆与特性分析。NKR-P1B/D配体是破骨细胞抑制性凝集素(Ocil),也称为Clr-b,它是先前克隆的一组与小鼠NK基因复合体(NKC)中的NKR-P1受体相关的C型凝集素相关(Clr)蛋白的成员。Ocil/Clr-b在小鼠肿瘤细胞系上的表达可抑制NK细胞介导的杀伤作用。用一种针对Ocil/Clr-b的新型单克隆抗体(4A6)可阻断这种抑制作用。通过使用4A6单克隆抗体,我们证明Ocil/Clr-b在几乎所有造血细胞上都高水平表达,但红细胞除外,其表达模式与I类MHC分子相似。值得注意的是,Ocil/Clr-b在小鼠肿瘤细胞系上经常下调,表明该受体-配体系统在肿瘤细胞“缺失自我识别”的新形式中发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索